Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ackerman, A.L. and Cresswell, P. 2004. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5:678–684
Aderem, A. and Underhill, D.M. 1999. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:593–623
Akira, S. and Takeda, K. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499–511
Albert, M.L., Pearce, S.F., Francisco, L.M., Sauter, B., Roy, P., Silverstein, R.L., and Bhardwaj, N. 1998. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1359–1368
Amyere, M., Mettlen, M., Van, D., Platek, A., Payrastre, B., Veithen, A., and Courtoy, P.J. 2002. Origin, originality, functions, subversions and molecular signalling of macropinocytosis. Int. J. Med. Microbiol. 291:487–494
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B., and Palucka, K. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767–811
Banchereau, J. and Steinman, R.M. 1998. Dendritic cells and the control of immunity. Nature 392:245–252
Bouvier, M. 2003. Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective. Mol. Immunol. 39:697–706
Cannons, J.L. and Schwartzberg, P.L. 2004. Fine-tuning lymphocyte regulation: what’s new with tyrosine kinases and phosphatases? Curr. Opin. Immunol. 16:296–303
Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I., and Banchereau, J. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263–1272
Cella, M., Engering, A., Pinet, V., Pieters, J., and Lanzavecchia, A. 1997a. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388:782–787
Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I., and Lanzavecchia, A. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:821–829
Cella, M., Sallusto, F., and Lanzavecchia, A. 1997b. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10–16
Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., Valvano, M.A., Foster, S.J., Mak, T.W., Nunez, G., and Inohara, N. 2003. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4:702–707
Chan, E.Y. and MacLennan, I.C. 1993. Only a small proportion of splenic B cells in adults are short-lived virgin cells. Eur. J. Immunol. 23:357–363
Cooke, M.P., Heath, A.W., Shokat, K.M., Zeng, Y., Finkelman, F.D., Linsley, P.S., Howard, M., and Goodnow, C.C. 1994. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J. Exp. Med. 179:425–438
Cornall, R.J., Goodnow, C.C., and Cyster, J.G. 1995. The regulation of self-reactive B cells. Curr. Opin. Immunol. 7:804–811
Coutinho, A., Gronowicz, E., and Moller, G. 1975. Mechanism of B-Cell Activation and Paralysis by Thymus-Independent Antigens – Additive Effects Between Nnp-Lps and Lps in Specific Response to Hapten. Scand. J. Immunol. 4:89–94
Cresswell, P. 1996. Invariant chain structure and MHC class II function. Cell 84:505–507
Cresswell, P., Bangia, N., Dick, T., and Diedrich, G. 1999. The nature of the MHC class I peptide loading complex. Immunol. Rev. 172:21–28
De Boer, R.J. and Perelson, A.S. 1993. How diverse should the immune system be? Proc. Biol. Sci. 252:171–175
Delamarre, L., Pack, M., Chang, H., Mellman, I., and Trombetta, E.S. 2005. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307:1630–1634
Dustin, M.L. and Cooper, J.A. 2000. The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. Nat. Immunol. 1:23–29
Erikson, J., Radic, M.Z., Camper, S.A., Hardy, R.R., Carmack, C., and Weigert, M. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349:331–334
Fanger, N.A., Wardwell, K., Shen, L., Tedder, T.F., and Guyre, P.M. 1996. Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. J. Immunol. 157:541–548
Fisher, G.H., Rosenberg, F.J., Straus, S.E., Dale, J.K., Middleton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J., and Puck, J.M. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935–946
Fluckiger, A.C., Li, Z.M., Kato, R.M., Wahl, M.I., Ochs, H.D., Longnecker, R., Kinet, J.P., Witte, O.N., Scharenberg, A.M., and Rawlings, D.J. 1998. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J. 17:1973–1985
Gallucci, S., Lolkema, M., and Matzinger, P. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5:1249–1255
Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287–299
Girardin, S.E., Boneca, I.G., Carneiro, L.A.M., Antignac, A., Jehanno, M., Viala, J., Tedin, K., Taha, M.K., Labigne, A., Zahringer, U., Coyle, A.J., Bertin, J., Sansonetti, P.J., and Philpott, D.J. 2003a. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 300:1584–1587
Girardin, S.E., Boneca, I.G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D.J., and Sansonetti, P.J. 2003b. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:8869–8872
Girardin, S.E., Tournebize, R., Mavris, M., Page, A.L., Li, X., Stark, G.R., Bertin, J., DiStefano, P.S., Yaniv, M., Sansonetti, P.J., and Philpott, D.J. 2001. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2:736–742
Gotter, J., Brors, B., Hergenhahn, M., and Kyewski, B. 2004. Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J. Exp. Med. 199:155–166
Gowans, J.L. 1996. The lymphocyte–a disgraceful gap in medical knowledge. Immunol. Today 17:288–291
Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., and Amigorena, S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621–667
Hart, D.N. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90:3245–3287
Hartley, S.B., Cooke, M.P., Fulcher, D.A., Harris, A.W., Cory, S., Basten, A., and Goodnow, C.C. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72:325–335
Hartley, S.B., Crosbie, J., Brink, R., Kantor, A.B., Basten, A., and Goodnow, C.C. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353:765–769
Healy, J.I. and Goodnow, C.C. 1998. Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 16:645–670
Hippen, K.L., Schram, B.R., Tze, L.E., Pape, K.A., Jenkins, M.K., and Behrens, T.W. 2005. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance. J. Immunol. 175:909–916
Inaba, K., Turley, S., Yamaide, F., Iyoda, T., Mahnke, K., Inaba, M., Pack, M., Subklewe, M., Sauter, B., Sheff, D., Albert, M., Bhardwaj, N., Mellman, I., and Steinman, R.M. 1998. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188:2163–2173
Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M., Foster, S.J., Moran, A.P., Fernandez-Luna, J.L., and Nunez, G. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. J. Biol. Chem. 278:5509–5512
Iyoda, T., Shimoyama, S., Liu, K., Omatsu, Y., Akiyama, Y., Maeda, Y., Takahara, K., Steinman, R.M., and Inaba, K. 2002. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195:1289–1302
Jacque, J. M., Triques, K., and Stevenson, M. 2002. Modulation of HIV-1 replication by RNA interference. Nature 418:435–438
Janeway, C.A. Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54 Pt 1:1–13
Janeway, C.A. Jr. and Bottomly, K. 1994. Signals and signs for lymphocyte responses. Cell 76:275–285
Jenkins, M.K. and Schwartz, R.H. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T-cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302–319
Jiang, W., Swiggard, W.J., Heufler, C., Peng, M., Mirza, A., Steinman, R.M., and Nussenzweig, M.C. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151–155
Kirchner, H., Korfer, A., Palmer, P.A., Evers, P., De Riese, W., Knuver-Hopf, J., Hadam, M., Goldman, U., Franks, C.R., and Poliwoda, H. 1990. Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experience. Mol. Biother. 2:145–154
Kleijmeer, M.J., Ossevoort, M.A., van Veen, C.J., van Hellemond, J.J., Neefjes, J.J., Kast, W.M., Melief, C.J., and Geuze, H.J. 1995. MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells. J. Immunol. 154:5715–5724
Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B., and Rock, K.L. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 90:4942–4946
Kovacsovics-Bankowski, M. and Rock, K.L. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267:243–246
Kropshofer, H., Hammerling, G.J., and Vogt, A.B. 1999. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules. Immunol. Rev. 172:267–278
Kunisawa, J. and Shastri, N. 2003. The group II chaperonin TRiC protects proteolytic intermediates from degradation in the MHC class I antigen processing pathway. Mol. Cell 12:565–576
Kyewski, B. and Klein, L. 2006. A central role for central tolerance. Annu. Rev. Immunol. 24:571–606
Lang, J., Jackson, M., Teyton, L., Brunmark, A., Kane, K., and Nemazee, D. 1996. B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J. Exp. Med. 184:1685–1697
Lanzavecchia, A. 1987. Antigen uptake and accumulation in antigen-specific B-cells. Immunol. Rev. 99:39–51
Lanzavecchia, A. 1990. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu. Rev. Immunol. 8:773–793
Leibson, P.J. 2004. The regulation of lymphocyte activation by inhibitory receptors. Curr. Opin. Immunol. 16:328–336
Lund, F.E., Garvy, B.A., Randall, T.D., and Harris, D.P. 2005. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr. Dir. Autoimmun. 8:25–54
MacLennan, I.C. and Gray, D. 1986. Antigen-driven selection of virgin and memory B cells. Immunol. Rev. 91:61–85
Mariathasan, S. and Monack, D.M. 2007. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 7:31–40
Marques, J.T. and Williams, B.R.G. 2005. Activation of the mammalian immune system by siRNAs. Nat. Biotechnol. 23:1399–1405
Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991–1045
Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296:301–305
Medzhitov, R. and Janeway, C.A. Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296:298–300
Medzhitov, R., Preston-Hurlburt, P., and Janeway, C.A. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394–397
Melchers, F. and Rolink, A.R. 2006. B cell tolerance – How to make it and how to break it. Curr. Concepts Autoimmun. Chron. Inflam. 305:1–23
Mellman, I. and Steinman, R.M. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255–258
Mempel, T.R., Henrickson, S.E., and von Andrian, U.H. 2004. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427:154–159
Miller, J.F. and Basten, A. 1996. Mechanisms of tolerance to self. Curr. Opin. Immunol. 8:815–821
Mosmann, T.R. and Coffman, R.L. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145–173
Nemazee, D. 1996. Antigen receptor ‘capacity’ and the sensitivity of self-tolerance. Immunol. Today 17:25–29
Nemazee, D. and Hogquist, K.A. 2003. Antigen receptor selection by editing or downregulation of V(D)J recombination. Curr. Opin. Immunol. 15:182–189
Nemazee, D.A. and Burki, K. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337:562–566
Norbury, C.C., Chambers, B.J., Prescott, A.R., Ljunggren, H.G., and Watts, C. 1997. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27:280–288
Nouri-Shirazi, M., Banchereau, J., Fay, J., and Palucka, K. 2000. Dendritic cell based tumor vaccines. Immunol. Lett. 74:5–10
Pancer, Z. and Cooper, M.D. 2006. The evolution of adaptive immunity. Annu. Rev. Immunol. 24:497–518
Parker, D.C. 1993. T-Cell - Dependent B-Cell Activation. Annu. Rev. Immunol. 11:331–360
Perini, P., Facchinetti, A., Bulian, P., Massaro, A.R., De Pascalis, D., Bertolotto, A., Biasi, G., and Gallo, P. 2001. Interferon-beta (IFN-beta) antibodies in interferon-beta 1a-and interferon-beta 1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo. Eur. Cytokine Network 12:56–61
Pfeifer, J.D., Wick, M.J., Roberts, R.L., Findlay, K., Normark, S.J., and Harding, C.V. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359–362
Philpott, D.J. and Girardin, S.E. 2004. The role of Toll-like receptors and Nod proteins in bacterial infection. Mol. Immunol. 41:1099–1108
Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., and Beutler, B. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085–2088
Probst, H.C., McCoy, K., Okazaki, T., Honjo, T., and Van Den, B.M. 2005. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6:280–286
Randolph, G.J. 2001. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 13:267–274
Rathmell, J.C., Cooke, M.P., Ho, W.Y., Grein, J., Townsend, S.E., Davis, M.M., and Goodnow, C.C. 1995. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376:181–184
Rathmell, J.C., Fournier, S., Weintraub, B.C., Allison, J.P., and Goodnow, C.C. 1998. Repression of B7.2 on self-reactive B cells is essential to prevent proliferation and allow Fas-mediated deletion by CD4(+) T cells. J. Exp. Med. 188:651–659
Rathmell, J.C., Townsend, S.E., Xu, J.C., Flavell, R.A., and Goodnow, C.C. 1996. Expansion or elimination of B cells in vivo: dual roles for. Cell 87:319–329
Raychaudhuri, S. and Rock, K.L. 1998. Fully mobilizing host defense: building better vaccines. Nat. Biotechnol. 16:1025–1031
Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P., and Amigorena, S. 1999. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:371–380
Reis e Sousa, C., Stahl, P.D., and Austyn, J.M. 1993. Phagocytosis of antigens by Langerhans cells in vitro. J. Exp. Med. 178:509–519
Rescigno, M., Citterio, S., Thery, C., Rittig, M., Medaglini, D., Pozzi, G., Amigorena, S., and Ricciardi-Castagnoli, P. 1998. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. Proc. Natl. Acad. Sci. USA 95:5229–5234
Reth, M. 1995. The B-cell antigen receptor complex and co-receptors. Immunol. Today 16:310–313
Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P., and Amigorena, S. 1999. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell. Biol. 1:362–368
Rosenberg, A.S. 2006. Effects of protein aggregates: an immunologic perspective. AAPS J 8:E501–E507
Ross, C., Clemmesen, K.M., Svenson, M., Sorensen, P.S., Koch-Henriksen, N., Skovgaard, G.L., and Bendtzen, K. 2000. Immunogenicity of interferon-beta in multiple sclerosis patients: Influence of preparation, dosage, dose frequency, and route of administration. Ann. Neurol. 48:706–712
Rubartelli, A., Poggi, A., and Zocchi, M.R. 1997. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium. Eur. J. Immunol. 27:1893–1900
Ryff, J.C. 1997. Clinical investigation of the immunogenicity of interferon-alpha 2a. J. Interferon Cytokine Res. 17 Suppl 1:S29–S33
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., and Toda, M. 1995. Immunological self-tolerance maintained by activated T-cells expressing Il-2 receptor alpha-chains (Cd25) – breakdown of a single mechanism of self-tolerance causes various autoimmune-diseases. J. Immunol. 155:1151–1164
Sallusto, F., Cella, M., Danieli, C., and Lanzavecchia, A. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182:389–400
Sallusto, F. and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109–1118
Sansonetti, P.J. 2006. The innate signaling of dangers and the dangers of innate signaling. Nat. Immunol. 7:1237–1242
Sauter, B., Albert, M.L., Francisco, L., Larsson, M., Somersan, S., and Bhardwaj, N. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:423–434
Savill, J., Dransfield, I., Gregory, C., and Haslett, C. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2:965–975
Schellekens, H. 2002. Immunogenicity of therapeutic proteins: clinical implications and future prospects. Clin. Ther. 24:1720–1740
Schellekens, H. 2005. Factors influencing the immunogenicity of therapeutic proteins. Nephrol. Dial. Transpl. 20:3–9
Schwartz, R.H. 2003. T cell anergy. Annu. Rev. Immunol. 21:305–334
Shastri, N., Schwab, S., and Serwold, T. 2002. Producing nature’s gene-chips: The generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20:463–493
Singh, N.J. and Schwartz, R.H. 2006. Primer: mechanisms of immunologic tolerance. Nat. Clin. Pract. Rheumatol. 2:44–52
Singh-Jasuja, H., Scherer, H.U., Hilf, N., Arnold-Schild, D., Rammensee, H.G., Toes, R.E., and Schild, H. 2000. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur. J. Immunol. 30:2211–2215
Slepnev, V.I. and De Camilli, P. 2000. Accessory factors in clathrin-dependent synaptic vesicle endocytosis. Nat. Rev. Neurosci. 1:161–172
Smits, H.H., de Jong, E.C., Wierenga, E.A., and Kapsenberg, M.L. 2005. Different faces of regulatory DCs in homeostasis and immunity. Trends Immunol. 26:123–129
Squier, M.K. and Cohen, J.J. 1994. Cell-mediated cytotoxic mechanisms. Curr. Opin. Immunol. 6:447–452
Steinman, R.M., Inaba, K., Turley, S., Pierre, P., and Mellman, I. 1999. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum. Immunol. 60:562–567
Steinman, R.M. and Swanson, J. 1995. The endocytic activity of dendritic cells. J. Exp. Med. 182:283–288
Steinman, R.M., Turley, S., Mellman, I., and Inaba, K. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191:411–416
Surh, C.D. and Sprent, J. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100–103
Takeda, K. and Akira, S. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1–14
Tang, A., Amagai, M., Granger, L.G., Stanley, J.R., and Udey, M.C. 1993. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E- cadherin. Nature 361:82–85
Taniguchi, M., Harada, M., Kojo, S., Nakayama, T., and Wakao, H. 2003. The regulatory role of V alpha 14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:483–513
Tiegs, S.L., Russell, D.M., and Nemazee, D. 1993. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1009–1020
Trombetta, E.S. and Mellman, I. 2005. Cell biology of antigen processing in vitro and in vivo. Annu. Rev. Immunol. 23:975–1028
Turley, S.J., Inaba, K., Garrett, W.S., Ebersold, M., Unternaehrer, J., Steinman, R.M., and Mellman, I. 2000. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288:522–527
Villadangos, J.A., Bryant, R.A., Deussing, J., Driessen, C., Lennon-Dumenil, A.M., Riese, R.J., Roth, W., Saftig, P., Shi, G.P., Chapman, H.A., Peters, C., and Ploegh, H.L. 1999. Proteases involved in MHC class II antigen presentation. Immunol. Rev. 172:109–120
Vivier, E. and Malissen, B. 2005. Innate and adaptive immunity: specificities and signaling hierarchies revisited. Nat. Rev. Immunol. 6:17–21
von Andrian, U.H. and Mempel, T.R. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3:867–878
Vos, Q., Lees, A., Wu, Z.Q., Snapper, C.M., and Mond, J.J. 2000. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 176:154–170
Wardemann, H., Yurasov, S., Schaefer, A., Young, J.W., Meffre, E., and Nussenzweig, M.C. 2003. Predominant autoantibody production by early human B cell precursors. Science 301:1374–1377
Watts, C. 2001. Antigen processing in the endocytic compartment. Curr. Opin. Immunol. 13:26–31
Weaver, C.T., Harrington, L.E., Mangan, P.R., Gavrieli, M., and Murphy, K.M. 2006. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24:677–688
Wick, M.J. and Ljunggren, H.G. 1999. Processing of bacterial antigens for peptide presentation on MHC class I molecules. Immunol. Rev. 172:153–162
Yewdell, J.W., Norbury, C.C., and Bennink, J.R. 1999. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. Adv. Immunol. 73:1–77
Zerrahn, J., Held, W., and Raulet, D.H. 1997. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell 88:627–636
Zinkernagel, R.M. 2000. What is missing in immunology to understand immunity? Nat. Immunol. 1:181–185
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Foged, C., Sundblad, A. (2008). Immune Reactions Towards Biopharmaceuticals – a General, Mechanistic Overview. In: Weert, M.v., Møller, E.H. (eds) Immunogenicity of Biopharmaceuticals. Biotechnology: Pharmaceutical Aspects, vol VIII. Springer, New York, NY. https://doi.org/10.1007/978-0-387-75841-1_1
Download citation
DOI: https://doi.org/10.1007/978-0-387-75841-1_1
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-75840-4
Online ISBN: 978-0-387-75841-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)